BAXTER INTERNATIONAL INC. Company Baxter International Inc. Borsa Italiana
Equities
4BAX
US0718131099
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.44 EUR | +2.49% |
|
+1.81% | -10.19% |
Business Summary
- medicines and medical devices (33.8%): products intended for treating hemophilia (substitution clotting factors) and immune deficiencies (multi-purpose immunoglobins), and used in intensive care (human albumin) and biosurgery (fibrin adhesive, surgical gel, bone substitutes, hemostatic compresses, etc.);
- kidney dialysis drugs and equipment (30.1%);
- systems for delivering medications and intravenous therapy (15.2%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, etc.;
- other (20.1%).
Export accounts for 52.7% of net sales.
Number of employees: 60,000
Sales per Business
| USD in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Medical Products and Therapies
33.8
%
| - | - | 5,011 | 33.8 % | - |
Kidney Care
30.1
%
| - | - | 4,453 | 30.1 % | - |
Healthcare Systems and Technologies
20.3
%
| - | - | 3,013 | 20.3 % | - |
Pharmaceuticals
15.2
%
| - | - | 2,249 | 15.2 % | - |
Other
0.6
%
| - | - | 87 | 0.6 % | - |
Sales per region
| USD in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
United States
47.3
%
| 7,223 | 47.8 % | 7,000 | 47.3 % | -3.09% |
Rest of World
30.3
%
| - | - | 4,494 | 30.3 % | - |
Emerging Markets
22.4
%
| - | - | 3,319 | 22.4 % | - |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Joe Almeida
CEO | Chief Executive Officer | 61 | 30/09/15 |
Joel Grade
DFI | Director of Finance/CFO | 54 | 17/10/23 |
Reaz Rasul
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/16 |
Tobi Karchmer
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/18 |
Heather Knight
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/18 |
Clare Trachtman
IRC | Investor Relations Contact | - | 31/12/99 |
David Rosenbloom
LAW | General Counsel | - | 31/12/21 |
Darren Evans
PRN | Corporate Officer/Principal | - | 30/11/21 |
Heather Wechet
HRO | Human Resources Officer | - | 31/05/08 |
Lynn Pawelski
LAW | General Counsel | - | 31/03/18 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Stephen Oesterle
BRD | Director/Board Member | 73 | 05/02/17 |
Peter Wilver
BRD | Director/Board Member | 64 | 09/05/22 |
| Director/Board Member | 64 | 17/02/19 | |
| Director/Board Member | 63 | 31/12/18 | |
Joe Almeida
CEO | Chief Executive Officer | 61 | 30/09/15 |
Catherine Smith
BRD | Director/Board Member | 60 | 17/07/17 |
| Director/Board Member | 69 | 12/12/21 | |
| Director/Board Member | 66 | 20/08/23 | |
David Wilkes
BRD | Director/Board Member | 67 | 14/02/21 |
D. Shafer
BRD | Director/Board Member | 66 | 09/05/22 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 683,510,683 | 507,613,362 ( 74.27 %) | 173,930,493 ( 25.45 %) | 74.27 % |
Holdings
| Name | Equities | % | Valuation |
|---|---|---|---|
ALVOTECH 1.03% | 2,735,145 | 1.03% | 37,963,813 $ |
Company contact information
Group companies
| Name | Category and Sector |
|---|---|
Baxter (India) Pvt Ltd.
 Baxter (India) Pvt Ltd. Pharmaceuticals: MajorHealth Technology Baxter (India) Pvt Ltd. manufactures recombinant and plasma-based proteins that are used to treat hemophilia and other bleeding disorders in India. The firm also offers plasma based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shocks, and other chronic and acute blood related conditions. It offers products to healthcare professionals, patients, and caregivers in the areas of anaesthesia, biosurgery, clinical nutrition, critical care, haemophilia, infusion systems, pharmaceuticals and IV solutions, renal, kidney disease, and immune deficiency. The company is headquartered in Gurgaon, India. |
Pharmaceuticals: Major
|
Baxter Innovations & Business Solutions Pvt Ltd.
| |
Baxter Pharmaceuticals India Pvt Ltd.
 Baxter Pharmaceuticals India Pvt Ltd. Chemicals: Major DiversifiedProcess Industries Founded in 2005, Baxter Pharmaceuticals India Pvt Ltd. is a subsidiary of Baxter International, Inc. that manufactures chemical products. The company is based in Ahmedabad, India. |
Chemicals: Major Diversified
|
Gambro Lundia AB
 Gambro Lundia AB Medical DistributorsDistribution Services Gambro Lundia AB operates as a medical technology company. It develops, manufactures, and distributes products and treatments for kidney and liver dialysis, treatment of myeloma kidney, and other extracorporeal treatments for chronically and acutely ill patients. The firm also holds shares in other companies. The company was founded on February 18, 1953 and is headquartered in Lund, Sweden. |
Medical Distributors
|
Baxter (Malta) Trading Co. Ltd.
| |
Baxter World Trade SRL
 Baxter World Trade SRL Miscellaneous Commercial ServicesCommercial Services Founded in 1984, Baxter World Trade SRL is a Belgian company that provides management services. Part of Baxter International, Inc., the company is based in Lessines, Belgium. |
Miscellaneous Commercial Services
|
Baxter R & D Europe SRL
 Baxter R & D Europe SRL Medical/Nursing ServicesHealth Services Founded in 1954, Baxter R & D Europe SRL is a subsidiary of Baxter International, Inc. that provides healthcare services. The company is based in Braine-l'Alleud, Belgium. |
Medical/Nursing Services
|
Sector
Sales per Business
Sales per region
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -5.81% | 180B | |
| -1.63% | 106B | |
| -4.14% | 67.55B | |
| -6.56% | 46.11B | |
| +13.22% | 45.79B | |
| +6.13% | 41.61B | |
| +19.93% | 31.07B | |
| +13.61% | 24.77B | |
| -5.36% | 24.27B |
- Stock Market
- Equities
- BAX Stock
- 4BAX Stock
- Company Baxter International Inc.
